2015/01/01 by Zain Rizvi, Steven J. Hoffman · 1 citation
Immunology and Microbiology · Economics, Econometrics and Finance · Business, Management and Accounting · #Antibiotic Use and Resistance #Pharmaceutical Economics and Policy #Global Public Health Policies and Epidemiology
paper · doi:10.1111/jlme.12278
openalex publication_date 2015/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/26
Global collective action is needed to address the growing transnational threat of antibiotic resistance (ABR). Some commentators have recommended an international legal agreement as the most promising mechanism for coordinating such action. While much has been said about what must be done to address ABR, far less work has analyzed how or where such collective action should be facilitated - even though the success of any international agreement depends greatly on where it is negotiated and implemented. This article evaluates four different forums that states may use to develop an international legal agreement for antibiotic resistance: (1) a self-organized venue; (2) the World Health Organization; (3) the World Trade Organization; and (4) the United Nations General Assembly. The need for a multisectoral approach and the diverse institutional landscape suggest that an effective response may best be coordinated through linked action pursued through multiple forums.